Al-Razi Medical Co. (9572.SR)
SAR 55.9
(2.57%)
SAR 55.9
(2.57%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | 5.66 Million | 2.03 Million | -1.71 Million |
| Net Income | 685.96 Thousand | 2.01 Million | 2.16 Million |
| Depreciation & Amortization | 3.69 Million | 2.68 Million | 1.99 Million |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | 622.63 Thousand | -3.21 Million | -6.55 Million |
| Other non-cash items | 7.13 Million | 9.37 Million | 10.94 Million |
| Investing Cash Flow | -5.04 Million | -2.92 Million | -1.15 Million |
| Investments in PPE | -5.06 Million | -2.92 Million | -1.15 Million |
| Acquisitions | 25 Thousand | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -5.04 Million | - | - |
| Financing Cash Flow | -1.17 Million | -5.43 Million | 10.33 Million |
| Debt repayment | -2.7 Million | -750 Thousand | -750 Thousand |
| Dividends payments | -2.41 Million | -1.88 Million | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | -670 Thousand | 12.35 Million |
| Other Financing Activities | 515.78 Thousand | - | - |
| Accounts receivables | -102.71 Thousand | 40.29 Thousand | -3.57 Million |
| Accounts payables | 587.72 Thousand | 1.8 Million | -1.07 Million |
| Inventory | 429.26 Thousand | -5.3 Million | -1.61 Million |
| Other working capital | -291.64 Thousand | 243.29 Thousand | -284.46 Thousand |
| Cash at beginning of period | 1.25 Million | 7.57 Million | 111.29 Thousand |
| Cash at end of period | 700.39 Thousand | 1.25 Million | 7.57 Million |
| Capital Expenditure | -5.06 Million | -2.92 Million | -1.15 Million |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -551.98 Thousand | -6.32 Million | 7.46 Million |
| Free Cash Flow | 596.24 Thousand | -892 Thousand | -2.86 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5064.00 | 5064.00 | 685.96 Thousand | 39.82 Thousand | 39.82 Thousand | 303.15 Thousand |
| Depreciation & Amortization | 970.96 Thousand | 970.96 Thousand | 3.69 Million | 936.48 Thousand | 936.48 Thousand | 909.12 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -128.63 Thousand | -128.63 Thousand | 622.63 Thousand | 572.59 Thousand | 572.59 Thousand | -531 Thousand |
| Other non-cash items | 1 Million | 1 Million | 7.13 Million | -366.99 Thousand | -366.99 Thousand | 1.02 Million |
| Investing Cash Flow | -784.21 Thousand | -784.21 Thousand | -5.04 Million | -2.41 Million | -2.41 Million | -105.96 Thousand |
| Investments in PPE | -784.21 Thousand | -784.21 Thousand | -5.06 Million | -2.28 Million | -2.28 Million | -100.52 Thousand |
| Acquisitions | - | - | 25 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -125.57 Thousand | -125.57 Thousand | -5444.00 |
| Financing Cash Flow | -1.06 Million | -1.06 Million | -1.17 Million | 285.35 Thousand | 285.35 Thousand | -928.73 Thousand |
| Debt repayment | -455.79 Thousand | - | -2.7 Million | - | - | - |
| Dividends payments | - | - | -2.41 Million | -299.4 Thousand | -299.4 Thousand | -906.94 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.06 Million | -1.06 Million | 515.78 Thousand | 584.75 Thousand | 584.75 Thousand | -21.79 Thousand |
| Accounts receivables | -252.2 Thousand | -252.2 Thousand | -102.71 Thousand | 91.67 Thousand | 91.67 Thousand | -104.22 Thousand |
| Accounts payables | 2.1 Million | - | 587.72 Thousand | - | - | - |
| Inventory | -56.37 Thousand | -56.37 Thousand | 429.26 Thousand | 484.92 Thousand | 484.92 Thousand | -270.29 Thousand |
| Other working capital | 179.94 Thousand | 179.94 Thousand | -291.64 Thousand | -4001.00 | -4001.00 | -156.49 Thousand |
| Cash at beginning of period | 700.39 Thousand | - | 1.25 Million | - | 2.59 Million | 1.92 Million |
| Cash at end of period | 696.81 Thousand | -1791.00 | 700.39 Thousand | -947.97 Thousand | 1.64 Million | 2.59 Million |
| Capital Expenditure | -784.21 Thousand | -784.21 Thousand | -5.06 Million | -2.28 Million | -2.28 Million | -100.52 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3582.00 | -1791.00 | -551.98 Thousand | -947.97 Thousand | -947.97 Thousand | 671.97 Thousand |
| Free Cash Flow | 1.06 Million | 1.06 Million | 596.24 Thousand | -1.1 Million | -1.1 Million | 1.6 Million |
LMPX
NTV
KOGMF
ACAB
600668
ASHCAP